BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3610Biotechnology
$9.82 −$0.01 (-0.10%)
Pre-market · Oct 8, 8:20 am ET · After hours $9.82 0.00%
Open$9.77
Prev close$9.83
Day range$9.60 – $10.14
Volume1.32M
Market cap$610.35M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership38.7%-11.14 pts vs. prior quarter
Institutions holding89-2 vs. prior quarter
Insider trades (recent)36 buys / 2 sellsNet buying
Short interest3.62% of floatDays to cover 2.5 · as of 15 Sep 2026
Short-sale volume share13.7%5-day average of daily volume

Short-sale volume as % of daily volume

8%12%15%19%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.87M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$637.2KSuper−$1.2MBig−$972.2KMid−$2.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 28.2% of shares outstanding.

Largest holders

  • Richard Griffiths7.97%
  • Robert Keith6.81%
  • TCG Crossover Management, LLC5.04%
  • Artal Group S.A.4.82%
  • Redmile Group, LLC3.60%
  • Nantahala Capital Management, LLC2.24%
  • Citadel Advisors LLC2.21%
  • Nextech Invest Ltd.1.58%

By investor type

  • Hedge Fund17.01%
  • Individual/Insider14.84%
  • VC/PE Fund12.98%
  • Mutual Fund5.96%
  • Private Company1.66%
  • Public Company1.07%

Reported short interest has fallen from 3.67% to 3.62% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +586,001 1.0%
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +630,000 1.0%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +610,980 1.0%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +370,052 0.6%
Morgan Stanley Public Company 2026/Q3 +337,686 0.7%
Crestline Investors Inc. Hedge Fund 2026/Q3 +326,648 0.5%
Schonfeld Strategic Advisors LLC Hedge Fund 2026/Q3 +269,348 0.4%
Jane Street Group, LLC Private Company 2026/Q3 +268,224 0.6%
Propel Bio Management, LLC Mutual Fund 2026/Q3 +191,733 0.3%
Fred Alger Management, LLC Mutual Fund 2026/Q3 +177,000 0.3%
ADAR1 Capital Management, LLC Hedge Fund 2026/Q3 +166,216 0.6%
Caption Management, LLC Hedge Fund 2026/Q3 +162,476 0.3%
Tetragon Partners UK LLP Hedge Fund 2026/Q3 +134,095 1.3%
Quadrature Capital Limited Hedge Fund 2026/Q3 +118,129 0.2%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +104,801 0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Jul 2026 Richard Griffiths Private Disposition -1,544,374 – 10,281,486
1 Jan 2026 Timothy McInerney Director Other Derivative Acquisition +90,000 $2.05 90,000
1 Jan 2026 David Lemus Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.05 90,000
1 Jan 2026 James Ede-Golightly Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.05 90,000
1 Jan 2026 Steven Romano Chief Medical Officer and Head of Research & Development Other Derivative Acquisition +300,000 $2.05 300,000
1 Jan 2026 Rhonda Hellums Chief Financial Officer Other Derivative Acquisition +375,000 $2.05 375,000
21 Dec 2025 James Ede-Golightly Independent Non-Executive Director Other Derivative Acquisition +90,000 $2.15 90,000
17 Dec 2025 Ian Ross Other Derivative Acquisition +900,000 $2.08 900,000
13 Dec 2025 James Ede-Golightly Independent Non-Executive Director Initial Statement of Beneficial +0 – 105,333
26 Oct 2025 Richard Griffiths Other Derivative Acquisition +2,000 $7.75 11,819,861
26 Oct 2025 Richard Griffiths Open Market Derivative Acquisiti +22,000 $7.75 11,825,861
2 Aug 2025 Richard Griffiths Open Market Derivative Dispositi -20,000 $5.45 11,805,861
31 Jul 2025 Richard Griffiths Private Acquisition +18,376 – 11,220,687
29 Jul 2025 Richard Griffiths Private Acquisition +23,482 – 11,202,311
10 Jul 2025 Richard Griffiths Private Acquisition +71,293 – 11,153,484
8 Jul 2025 Richard Griffiths Private Acquisition +62,457 – 11,082,191
26 Jun 2025 Richard Griffiths Private Acquisition +110,474 – 11,019,734
23 Jun 2025 Richard Griffiths Private Acquisition +82,606 – 10,909,260
17 Jun 2025 Richard Griffiths Open Market Acquisition +70,448 $5.29 10,826,654
11 Jun 2025 Richard Griffiths Private Acquisition +39,305 – 10,756,206

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 2,178,055 3.6% 2.5
31 Aug 2026 2,435,831 4.0% 3.5
14 Aug 2026 2,432,830 4.0% 1.0
31 Jul 2026 1,837,238 3.9% 3.3
15 Jul 2026 1,572,687 3.3% 3.2
30 Jun 2026 1,733,018 3.7% 2.2

Discussion

No comments yet — be the first to weigh in on SLN.

Leave a comment

Scroll to Top